Everything tagged "medical instruments and supplies" across the TickerSpark archives.
Cooper Companies posted 8% revenue growth and 26% non-GAAP EPS growth in Q2, with premium contact lenses and fertility driving the story. A strategic review at CooperSurgical adds a potential value catalyst, while debt and Asia Pacific weakness keep the risk profile moderate.
Intuitive Surgical posted 19% Q2 2026 revenue growth, driven by a larger da Vinci installed base and a recurring revenue mix that reached 85% of quarterly sales. The stock still earns only a Hold as a premium valuation limits upside despite strong operating momentum.
ResMed pairs double-digit revenue growth, strong margins, and net cash with a large underpenetrated sleep-apnea market. The stock remains a Buy, but valuation and an Astral field-action headwind temper upside.
Medline is growing quickly, but heavy debt and margin pressure keep the stock in disciplined Buy territory. The report sees solid medium-term upside, with fair value above the recent trading price.
Align Technology combines a strong balance sheet, improving margins, and a leading Invisalign franchise, but 2026 growth guidance remains modest. The stock looks attractive for moderate-risk investors if margin recovery and international demand continue to build.
Alcon is pairing strong Unity equipment momentum with faster dry-eye growth, while cash flow and buybacks support the bull case. Valuation is not cheap, but guidance and mix shift keep the stock constructive.
Generate AI research on any ticker — grades, price targets, and full analysis in minutes.
Open the GeneratorCancel anytime